The FDA-approved, next-generation sequencing-based companion diagnostic rapidly identifies non-small cell lung cancer patients eligible for targeted therapies Ft. Myers, Florida –NeoGenomics, Inc. (NASDAQ: NEO), ), a leading global specialty oncology testing laboratory, has signed an agreement with Thermo Fisher Scientific to join the Next-Generation Sequencing Companion Dx Center of Excellence Program (COEP). NeoGenomics is one of […]

Combines Molecular Spectroscopy Techniques with Analytical Chemistry Expertise to Uncover Nutritional Value of Food WALTHAM, Mass–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced a collaboration with TeakOrigin, a company that integrates technology and data platforms to serve as a detector for food authenticity and quality. PerkinElmer’s cutting-edge molecular spectroscopy instrumentation, […]

Location: Cambridge Breadth of research use rights now expanded to include multiple new species Grant of rights to have products made and sold by partners Grant of sub-licensed rights to one spin-out company Cambridge, UK, and Dublin, Ireland: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in gene editing and […]

SAN DIEGO, CA and CAMBRIDGE, MA — Edico Genome and Seven Bridges today announced the availability of Edico Genome’s DRAGENTM pipelines within Seven Bridges’ cloud-based data ecosystem. Edico Genome’s DRAGEN Germline V2, DRAGEN Somatic V2 and DRAGEN RNA Gene Fusion Detection Pipelines are now live on the Seven Bridges platform, enabling customers to leverage DRAGEN’s ultra rapid speeds and accuracy. Seven Bridges […]

IPSWICH, Mass. and VILNIUS, Lithuania — New England Biolabs, Inc. (NEB®) and CasZyme, a recently-formed startup company based in Vilnius, Lithuania, announced today that they have entered into a multi-year collaboration to identify and commercialize CRISPR-Cas nucleases, with the goal of providing researchers with additional tools for genome editing and molecular biology applications. Under the terms of the agreement, […]

Our distributor agreement with BIOZOL expands the availability of the Novallele™ genotyping and copy number assays MELVILLE, N.Y. Canon BioMedical is pleased to announce our latest geographic expansion into the German-speaking countries of Austria, Germany, and Switzerland. We are working with a new distributor, BIOZOL Diagnostica Vertrieb GmbH, that will distribute all of the Novallele […]

Shimadzu Corporation, Fujitsu Limited, and Fujitsu Laboratories Ltd. are undertaking collaborative research*1to develop technology that utilizes AI (artificial intelligence) to process the vast amounts of data used in analyzing the measurement results, which are essential to analytical processes, acquired from Shimadzu mass spectrometers. Fujitsu, an information and communication technology company, has been exploring the creation […]

Strong demand predicted across all life science markets Amsterdam: Dutch biotechnology company Molecular Biology Systems (MBS) today announced it will launch its revolutionary NEXTGENPCR thermal cycler through AMPLITECH, an independent commercial organization offering innovative solutions to the public and private in vitro diagnostic testing market, including cytogenetics, molecular genetics, and pathology labs, in France, Belgium, Luxembourg, and Switzerland. […]

LGC and NuGEN have today announced a collaboration agreement for the commercialisation of the Single Primer Enrichment Technology (SPET) and distribution of Allegro Targeted Genotyping reagents for NGS library preparation. This collaboration will benefit customers of both LGC and NuGEN, as it expands options to access the SPET technology through the SeqSNP service in LGC’s global service […]

Pioneer of real-time cell analysis instrumentation will join forces with leading provider of iPSC-derived cardiomyocytes SAN DIEGO ACEA Biosciences (ACEA), a pioneer and leader in label-free real-time cell analysis instrumentation, and Ncardia, a leading expert in human cardiovascular stem cell technology, disease modelling and cell-based assay products and services, announced today that they have established […]